|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online July 23, 2007
doi: 10.1242/10.1242/jcs.001222
Commentary |
1 Cancer Center and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA
2 Departments of Urology and Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
* Author for correspondence (e-mail: huang253{at}umn.edu)
Accepted 13 June 2007
Forkhead box O (FoxO) transcription factors FoxO1, FoxO3a, FoxO4 and FoxO6, the mammalian orthologs of Caenorhabditis elegans DAF-16, are emerging as an important family of proteins that modulate the expression of genes involved in apoptosis, the cell cycle, DNA damage repair, oxidative stress, cell differentiation, glucose metabolism and other cellular functions. FoxO proteins are regulated by multiple mechanisms. They undergo inhibitory phosphorylation by protein kinases such as Akt, SGK, IKK and CDK2 in response to external and internal stimuli. By contrast, they are activated by upstream regulators such as JNK and MST1 under stress conditions. Their activities are counterbalanced by the acetylases CBP and p300 and the deacetylase SIRT1. Also, whereas polyubiquitylation of FoxO1 and FoxO3a leads to their degradation by the proteasome, monoubiquitylation of FoxO4 facilitates its nuclear localization and augments its transcriptional activity. Thus, the potent functions of FoxO proteins are tightly controlled by complex signaling pathways under physiological conditions; dysregulation of these proteins may ultimately lead to disease such as cancer.
Key words: Akt, CDK2, FoxO, Cancer, Phosphorylation, Ubiquitylation
This article has been cited by other articles:
|
|
 |
|
  A. Dubrovska, S. Kim, R. J. Salamone, J. R. Walker, S.-M. Maira, C. Garcia-Echeverria, P. G. Schultz, and V. A. Reddy The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations PNAS, January 6, 2009; 106(1): 268 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Liu, S. Li, L. Gan, T. P. Kao, and H. Huang A Transcription-Independent Function of FOXO1 in Inhibition of Androgen-Independent Activation of the Androgen Receptor in Prostate Cancer Cells Cancer Res., December 15, 2008; 68(24): 10290 - 10299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Weidinger, K. Krause, A. Klagge, S. Karger, and D. Fuhrer Forkhead box-O transcription factor: critical conductors of cancer's fate Endocr. Relat. Cancer, December 1, 2008; 15(4): 917 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-Y. Liu, G.-B. Wen, J. Han, T. Hong, D. Zhuo, Z. Liu, and W. Cao Inhibition of Gluconeogenesis in Primary Hepatocytes by Stromal Cell-derived Factor-1 (SDF-1) through a c-Src/Akt-dependent Signaling Pathway J. Biol. Chem., November 7, 2008; 283(45): 30642 - 30649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Krum, G. A. Miranda-Carboni, M. Lupien, J. Eeckhoute, J. S. Carroll, and M. Brown Unique ER{alpha} Cistromes Control Cell Type-Specific Gene Regulation Mol. Endocrinol., November 1, 2008; 22(11): 2393 - 2406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lupertz, Y. Chovolou, K. Unfried, A. Kampkotter, W. Watjen, and R. Kahl The forkhead transcription factor FOXO4 sensitizes cancer cells to doxorubicin-mediated cytotoxicity Carcinogenesis, November 1, 2008; 29(11): 2045 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Hammers, E. K. Merritt, W. Matheny, M. L. Adamo, T. J. Walters, J. S. Estep, and R. P. Farrar Functional deficits and insulin-like growth factor-I gene expression following tourniquet-induced injury of skeletal muscle in young and old rats J Appl Physiol, October 1, 2008; 105(4): 1274 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Gao and J. Zhang Spatiotemporal Analysis of Differential Akt Regulation in Plasma Membrane Microdomains Mol. Biol. Cell, October 1, 2008; 19(10): 4366 - 4373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mattila, J. Kallijarvi, and O. Puig RNAi screening for kinases and phosphatases identifies FoxO regulators PNAS, September 30, 2008; 105(39): 14873 - 14878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kodiha, C. M. Brown, and U. Stochaj Analysis of Signaling Events by Combining High-Throughput Screening Technology with Computer-Based Image Analysis Sci. Signal., September 16, 2008; 1(37): pl2 - pl2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dehner, M. Hadjihannas, J. Weiske, O. Huber, and J. Behrens Wnt Signaling Inhibits Forkhead Box O3a-induced Transcription and Apoptosis through Up-regulation of Serum- and Glucocorticoid-inducible Kinase 1 J. Biol. Chem., July 11, 2008; 283(28): 19201 - 19210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sandri Signaling in Muscle Atrophy and Hypertrophy Physiology, June 1, 2008; 23(3): 160 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Zaballos, B. Garcia, and P. Santisteban G{beta}{gamma} Dimers Released in Response to Thyrotropin Activate Phosphoinositide 3-Kinase and Regulate Gene Expression in Thyroid Cells Mol. Endocrinol., May 1, 2008; 22(5): 1183 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Evans-Anderson, C. M. Alfieri, and K. E. Yutzey Regulation of Cardiomyocyte Proliferation and Myocardial Growth During Development by FOXO Transcription Factors Circ. Res., March 28, 2008; 102(6): 686 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. G. Ni, N. Wang, D. J. Cao, N. Sachan, D. J. Morris, R. D. Gerard, M. Kuro-o, B. A. Rothermel, and J. A. Hill FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases PNAS, December 18, 2007; 104(51): 20517 - 20522. [Abstract] [Full Text] [PDF]
|
|
